A
ALMR
Alamar Biosciences
30.71
-2.29-6.94%After Hours: 30.71 0.00 0.00%19:30 08/28 EDT
OPEN/PREV CLOSE32.70/33.00
TODAY RANGE30.46-33.54
VOL267.64K
MARKET CAP2.13B
52 WEEK RANGE18.85-38.54
AVG VOL (3M)324.53K
% TURNOVER0.39%
TURNOVER--
P/E (TTM)-60.1214
% RANGE9.35%
EPS(TTM)-0.5108
P/E(FORWARD)-25.2448
P/B6.81
BVPS4.509
DIVIDEND--
P/S27.53
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.56B
SHARES OUTSTANDING69.39M
NEXT EARNINGS--
FREE FLOAT50.90M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·08/16 12:15
Alamar Biosciences: Promising But Expensive Proteomics Growth
Seeking Alpha·08/14 04:43
Alamar Biosciences: The Content Flywheel Is More Valuable Than The Instrument
Benzinga·08/12 12:58
Top 3 Health Care Stocks That May Implode In August
Simply Wall St·08/12 07:26
Alamar Biosciences (ALMR) Stock Price Jumps As Margin Gains Meet Loss Pressure
TipRanks·08/12 00:14
Alamar Biosciences Earnings Call Signals Aggressive Growth
Dow Jones·08/11 17:51
Alamar Biosciences Is Maintained at Buy by Stifel
Benzinga·08/11 17:41
Stifel Maintains Buy on Alamar Biosciences, Raises Price Target to $32
Benzinga·08/11 17:25
Alamar Biosciences Stock Soars, CEO Says Company Is Well-Positioned to Sustain Upcoming Momentum
Benzinga·08/11 17:06
12 Health Care Stocks Moving In Tuesday's Intraday Session
Dow Jones·08/11 14:20
Alamar Biosciences Price Target Raised to $35.00/Share From $32.00 by JP Morgan
Dow Jones·08/11 14:20
Alamar Biosciences Is Maintained at Overweight by JP Morgan
Benzinga·08/11 14:09
JP Morgan Maintains Overweight on Alamar Biosciences, Raises Price Target to $35
Same Industry
Name/Symbol
Change%
Price